Buchumschlag

Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma

Purpose: This study aims to examine the health-related quality of life in patients with hepatocellular carcinoma. Methods: 181 patients attending a tertiary center outpatient clinic were interviewed and completed the short form 36 (SF36) questionnaire. The SF36 was used to assess health-related QoL....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wehling, Cyrill (VerfasserIn) , Hornuß, Daniel (VerfasserIn) , Springfeld, Christoph (VerfasserIn) , Hoffmann, Katrin (VerfasserIn) , Chang, De-Hua (VerfasserIn) , Naumann, Patrick (VerfasserIn) , Mieth, Markus (VerfasserIn) , Longerich, Thomas (VerfasserIn) , Kratochwil, Clemens (VerfasserIn) , Mehrabi, Arianeb (VerfasserIn) , Gauss, Annika (VerfasserIn) , Weiss, Karl Heinz (VerfasserIn) , Pfeiffenberger, Jan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 August 2019
In: Journal of cancer research and clinical oncology
Year: 2019, Jahrgang: 145, Heft: 11, Pages: 2761-2769
ISSN:1432-1335
DOI:10.1007/s00432-019-03005-y
Online-Zugang:Verlag, Volltext: https://doi.org/10.1007/s00432-019-03005-y
Volltext
Verfasserangaben:Cyrill Wehling, Daniel Hornuss, Pasquale Schneider, Christoph Springfeld, Katrin Hoffmann, De-Hua Chang, Patrick Naumann, Markus Mieth, Thomas Longerich, Clemens Kratochwil, Arianeb Mehrabi, Annika Gauss, Karl Heinz Weiss, Jan Pfeiffenberger
Beschreibung
Zusammenfassung:Purpose: This study aims to examine the health-related quality of life in patients with hepatocellular carcinoma. Methods: 181 patients attending a tertiary center outpatient clinic were interviewed and completed the short form 36 (SF36) questionnaire. The SF36 was used to assess health-related QoL. Cross-sectional analyses by group (age, gender, clinical scores, systemic, and local interventions) as well sequel questionnaires were conducted. Results: Participants included were 79% (143/181) men [mean age at first SF36: 63.8 (± 12.3; 18.4-85.8) years]. Barcelona Clinic Liver Cancer (BCLC) stadium C was associated with significantly lower SF36 total scores, and elevated initial alpha-fetoprotein (AFP) concentrations were associated with lower SF36 functional and mental health sum scores throughout the course of the third questionnaire. Patients treated with sorafenib had within the sub-dimension scores a significantly lower result for role limitations due to physical health compared to patients without sorafenib treatment. Patients who underwent a transarterial chemoembolization (TACE) had within the sub-dimension scores a significantly higher result for control of pain compared to patients without TACE. Kaplan-Meier analysis revealed significant survival benefits for patients who underwent any intervention at the first SF36 (mean survival in years 4.3 vs. 1.6; P < 0.01) as well as for patients who underwent hepatic resection (mean survival in years 6.3 vs. 2.7; P < 0.0001). Conclusion: Advanced tumor stages marked by BCLC stadium C and elevated initial AFP concentrations were associated with lower SF36 total scores and functional sum scores, respectively. During the course of sorafenib treatment, the sub-dimensional score for role limitations due to physical health decreased significantly, whereas TACE performance was associated with a significant improvement of the control of body pain.
Beschreibung:Gesehen am 14.11.2019
Beschreibung:Online Resource
ISSN:1432-1335
DOI:10.1007/s00432-019-03005-y

Ähnliche Einträge